- Home
- AAM vs YMAB Comparison
AAM vs YMAB Comparison
Compare AAM & YMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAM
- YMAB
- Stock Information
- Founded
- AAM 2024
- YMAB 2015
- Country
- AAM United States
- YMAB United States
- Employees
- AAM N/A
- YMAB N/A
- Industry
- AAM
- YMAB Biotechnology: Pharmaceutical Preparations
- Sector
- AAM
- YMAB Health Care
- Exchange
- AAM Nasdaq
- YMAB Nasdaq
- Market Cap
- AAM 460.0M
- YMAB 386.7M
- IPO Year
- AAM 2024
- YMAB 2018
- Fundamental
- Price
- AAM N/A
- YMAB $8.59
- Analyst Decision
- AAM
- YMAB Buy
- Analyst Count
- AAM 0
- YMAB 10
- Target Price
- AAM N/A
- YMAB $13.91
- AVG Volume (30 Days)
- AAM 65.5K
- YMAB 1.1M
- Earning Date
- AAM 01-01-0001
- YMAB 11-07-2025
- Dividend Yield
- AAM N/A
- YMAB N/A
- EPS Growth
- AAM N/A
- YMAB N/A
- EPS
- AAM 0.32
- YMAB N/A
- Revenue
- AAM N/A
- YMAB $85,385,000.00
- Revenue This Year
- AAM N/A
- YMAB N/A
- Revenue Next Year
- AAM N/A
- YMAB $13.97
- P/E Ratio
- AAM $32.57
- YMAB N/A
- Revenue Growth
- AAM N/A
- YMAB N/A
- 52 Week Low
- AAM $9.96
- YMAB $3.55
- 52 Week High
- AAM $10.79
- YMAB $16.11
- Technical
- Relative Strength Index (RSI)
- AAM 54.07
- YMAB 81.21
- Support Level
- AAM $10.47
- YMAB $8.50
- Resistance Level
- AAM $10.49
- YMAB $8.56
- Average True Range (ATR)
- AAM 0.02
- YMAB 0.02
- MACD
- AAM -0.00
- YMAB -0.14
- Stochastic Oscillator
- AAM 80.00
- YMAB 92.86
About AAM AA Mission Acquisition Corp. Class A Ordinary Shares
AA Mission Acquisition Corp is a blank check company.
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.